Recent Updates
Recently added Catalysts
IRWD Positive Sentiment

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

Thursday, July 25, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Ironwood Pharmaceuticals has announced it will host an investor update call for the second quarter of 2024. This call aims to provide insights into the company's performance and future plans. The event reflects Ironwood's commitment to maintaining transparency and open communication with its stakeholders.
Price reaction · baseline $6.65 (2024-07-24 close) · hit after-hours · clean, no other IRWD news in the window
day 0 close
+2.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Ironwood Pharmaceuticals is actively engaging with investors.
  • The company is transparent about its operations and updates.
  • The investor update call indicates a commitment to communication.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+57%
120-day peak, hindsight
Typical move
3.8%
average across 2 past catalysts
Lead asset
IW-3718
Phase 3 · Gastroesophageal Reflux Disease (GERD)

Full Press Release Details

• Company Company Overview Leadership Open Payments & Transparency
• Science & Medicine Therapeutic Focus Pipeline Product
• Patients Overview
• Responsibility Overview Diversity, Equity & Inclusion Sustainability Safety & Compliance Patients & Research Community Giving
• Careers Working at Ironwood Internships, Co-ops and Fellowships Open Positions
• Investors & Media Contact Us
• Company Overview
• Leadership
• Open Payments & Transparency
• Therapeutic Focus
• Pipeline
• Product
• Overview
• Overview
• Diversity, Equity & Inclusion
• Sustainability
• Safety & Compliance
• Patients & Research
• Community Giving
• Working at Ironwood
• Internships, Co-ops and Fellowships
• Open Positions
• Investors & Media
• Contact Us

Frequently Asked Questions

When is Ironwood's Q2 2024 investor update call?

The exact date for Ironwood's Q2 2024 investor update call has not been specified.

What is the purpose of the investor update call?

The call aims to provide insights into Ironwood's performance and future plans.

How does Ironwood ensure transparency with investors?

Ironwood engages in open communication and provides regular updates to its stakeholders.

ShareAdd on Google
Tags: IRWD Viatris Investor Conferences Healthcare Ironwood Pharmaceuticals investor update Q2 2024 transparency
Last updated: Jul 25, 2024

Biotech snapshot

Cash runway
$79M liquidity · $0M/mo burn
Low dilution risk
Lead asset
IW-3718Phase 3
Gastroesophageal Reflux Disease (GERD) →

Catalyst track record

+57%
best trade around IRWD's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for IRWD.

See every catalyst's timing & PoA →